Cargando…
Translation control during prolonged mTORC1 inhibition mediated by 4E-BP3
Targeting mTORC1 is a highly promising strategy in cancer therapy. Suppression of mTORC1 activity leads to rapid dephosphorylation of eIF4E-binding proteins (4E-BP1–3) and subsequent inhibition of mRNA translation. However, how the different 4E-BPs affect translation during prolonged use of mTOR inh...
Autores principales: | Tsukumo, Yoshinori, Alain, Tommy, Fonseca, Bruno D., Nadon, Robert, Sonenberg, Nahum |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4915159/ https://www.ncbi.nlm.nih.gov/pubmed/27319316 http://dx.doi.org/10.1038/ncomms11776 |
Ejemplares similares
-
Repair of Isoaspartate Formation Modulates the Interaction of Deamidated 4E-BP2 with mTORC1 in Brain
por: Bidinosti, Michael, et al.
Publicado: (2010) -
mTOR inhibitor efficacy is determined by the eIF4E/4E-BP ratio
por: Alain, Tommy, et al.
Publicado: (2012) -
Deficiency in mTORC1-controlled C/EBPβ-mRNA translation improves metabolic health in mice
por: Zidek, Laura M, et al.
Publicado: (2015) -
mTORC1 mediated translational elongation limits intestinal tumour initiation and growth
por: Faller, William J., et al.
Publicado: (2014) -
CDK12 phosphorylates 4E-BP1 to enable mTORC1-dependent translation and mitotic genome stability
por: Choi, Seung H., et al.
Publicado: (2019)